1. Home
  2. NTAP vs PODD Comparison

NTAP vs PODD Comparison

Compare NTAP & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetApp Inc.

NTAP

NetApp Inc.

HOLD

Current Price

$117.21

Market Cap

22.2B

Sector

Technology

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.01

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTAP
PODD
Founded
1992
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2B
22.1B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
NTAP
PODD
Price
$117.21
$304.01
Analyst Decision
Buy
Strong Buy
Analyst Count
14
19
Target Price
$123.15
$359.00
AVG Volume (30 Days)
2.4M
765.6K
Earning Date
11-25-2025
11-06-2025
Dividend Yield
1.77%
N/A
EPS Growth
5.78
N/A
EPS
5.75
3.45
Revenue
$6,637,000,000.00
$2,521,800,000.00
Revenue This Year
$4.95
$32.55
Revenue Next Year
$4.87
$20.39
P/E Ratio
$20.40
$88.24
Revenue Growth
2.53
27.11
52 Week Low
$71.84
$230.05
52 Week High
$131.30
$354.88

Technical Indicators

Market Signals
Indicator
NTAP
PODD
Relative Strength Index (RSI) 59.71 40.94
Support Level $106.52 $303.20
Resistance Level $116.54 $317.34
Average True Range (ATR) 3.67 13.12
MACD 1.25 -2.82
Stochastic Oscillator 96.97 3.14

Price Performance

Historical Comparison
NTAP
PODD

About NTAP NetApp Inc.

NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: